• Home
  • Courses
  • Features
    • PACUPrep
    • Masterclasses
    • Reference Library
    • Live Seminars
    • Patient Cases
    • Literature Review
    • Our CE Courses
    • Blog Posts
      • Pharmacy Friday Pearls
  • PACULit Newsletter
  • PACUPrep
    • PACUPrep MPJE
  • About Us
    • Contact
  • Dashboard
  • Login
  • Home
  • Courses
  • Features
    • PACUPrep
    • Masterclasses
    • Reference Library
    • Live Seminars
    • Patient Cases
    • Literature Review
    • Our CE Courses
    • Blog Posts
      • Pharmacy Friday Pearls
  • PACULit Newsletter
  • PACUPrep
    • PACUPrep MPJE
  • About Us
    • Contact
  • Dashboard
  • Login
    Sign in Sign up
    Pharmacy & Acute Care University
    Pharmacy & Acute Care University
    • Home
    • Courses
    • Features
      • PACUPrep
      • Masterclasses
      • Reference Library
      • Live Seminars
      • Patient Cases
      • Literature Review
      • Our CE Courses
      • Blog Posts
        • Pharmacy Friday Pearls
    • PACULit Newsletter
    • PACUPrep
      • PACUPrep MPJE
    • About Us
      • Contact
    • Dashboard
    • Login

    Category: Cardiology

    CAPRICORN Trial Dargie HJ, et al. “Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial”. The Lancet. 2001. 357(9266):1385-1390.

    “` CAPRICORN Randomised Trial Analysis Article Identification Article Title: Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised…

    jimmyleepruittgmail-com
    Jimmy Pruitt November 23, 2024
    0 Comments

    AURORA Study . Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis”

    “` Effects of Rosuvastatin on Cardiovascular Events in Patients Undergoing Hemodialysis (AURORA Trial) Effects of Rosuvastatin on Cardiovascular Events in Patients Undergoing Hemodialysis (AURORA Trial)…

    jimmyleepruittgmail-com
    Jimmy Pruitt November 23, 2024
    0 Comments

    Bhatt DL, et al. “Effect of Platelet Inhibition with Cangrelor during PCI on Ischemic Events”. The New England Journal of Medicine. 2013. 368(14):1303-1313.

    jimmyleepruittgmail-com
    Jimmy Pruitt November 23, 2024
    0 Comments

    CAST Trial. Mortality and morbidity in patients receiving Encainide, Flecainide, or Placebo

    Table of Contents Clinical Literature Summary Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial Authors (Top 5): D.…

    jimmyleepruittgmail-com
    Jimmy Pruitt November 23, 2024
    0 Comments

    2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases

    Full Text PubMed 2014 ESC Guidelines on Aortic Diseases Introduction to Aortic Disease Guidelines Citation: Erbel R, Aboyans V, Boileau C, et al. 2014 ESC…

    jlpruitt
    Jimmy November 14, 2024
    0 Comments

    2014 ESC Guidelines on the diagnosis and treatment of aortic diseases – Copy

    jlpruitt
    Jimmy September 26, 2024
    0 Comments

    2014 ESC Guidelines on the Diagnosis and Treatment of Aortic Diseases

    EAU Guidelines on Urolithiasis (Limited Text Update March 2022) Authors: A. Skolarikos (Chair), A. Neisius, A. Petřík, B. Somani, K. Thomas, G. Gambaro Guidelines Associates:…

    jlpruitt
    Jimmy September 26, 2024
    0 Comments

    Management of Hypertensive Emergency

    Introduction Hypertensive emergency is characterized by systolic blood pressure (SBP) > 180 mmHg or diastolic blood pressure (DBP) > 120 mmHg with evidence of target…

    jlpruitt
    Jimmy February 23, 2023
    0 Comments

    Fibrinolytics for STEMI

    Introduction Percutaneous coronary intervention (PCI) is the preferred reperfusion strategy during a cardiac arrest; thrombolytic therapy is an option without PCI capability, followed by transfer…

    jlpruitt
    Jimmy February 16, 2023
    0 Comments

    Procainamide for Wide Complex Tachycardia

    Introduction Ventricular tachycardia (VT) is an uncommon but dangerous medical condition, with an extremely variable clinical presentation. Intravenous procainamide is guideline recommended and is the…

    jlpruitt
    Jimmy February 9, 2023
    0 Comments
    Load More
    © 2025 - Pharmacy & Acute Care University